You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-TARDBP antibody (ab50930)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-TARDBP antibody
See all TARDBP products (10) ...

Description

Rabbit polyclonal to TARDBP

Tested applications

WB, IHC-Pmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Mouse, Rat, Cow, Dog

Immunogen

A region within synthetic peptide: MSEYIRVTED ENDEPIEIPS EDDGTVLLST VTAQFPGACG LRYRNPVSQC, corresponding to N terminal amino acids 1-50 of Human TARDBP

MSEYIRVTED ENDEPIEIPS EDDGTVLLST VTAQFPGACG LRYRNPVSQC

Positive control

HepG2 cell lysate, Human liver and kidney tubules.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: 2% Sucrose, PBS

Concentration

Concentration information loading...

Purity

Protein A purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - TARDBP antibody (ab50930)Western blot - TARDBP antibody (ab50930) image (enlarge)

  • Immunohistochemistry (Paraffin-embedded sections) - TARDBP antibody (ab50930)Immunohistochemistry (Paraffin-embedded sections) - TARDBP antibody (ab50930) image (enlarge)

  • Immunohistochemistry (Paraffin-embedded sections) - TARDBP antibody (ab50930)Immunohistochemistry (Paraffin-embedded sections) - TARDBP antibody (ab50930) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab50930 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

DNA and RNA-binding protein which regulates transcription and splicing. Involved in the regulation of CFTR splicing. It promotes CFTR exon 9 skipping by binding to the UG repeated motifs in the polymorphic region near the 3'-splice site of this exon. The resulting aberrant splicing is associated with pathological features typical of cystic fibrosis. May also be involved in microRNA biogenesis, apoptosis and cell division. Can repress HIV-1 transcription by binding to the HIV-1 long terminal repeat. Stabilizes the low molecular weight neurofilament (NFL) mRNA through a direct interaction with the 3' UTR.

Tissue specificity

Ubiquitously expressed. In particular, expression is high in pancreas, placenta, lung, genital tract and spleen.

Involvement in disease

Defects in TARDBP are the cause of amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069]. ALS is a neurodegenerative disorder affecting upper and lower motor neurons and resulting in fatal paralysis. Sensory abnormalities are absent. Death usually occurs within 2 to 5 years. The etiology of ALS is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.

Sequence similarities

Contains 2 RRM (RNA recognition motif) domains.

Domain

The RRM domains can bind to both DNA and RNA.

Post-translational
modifications

Hyperphosphorylated in hippocampus, neocortex, and spinal cord from individuals affected with ALS and FTLDU.
Ubiquitinated in hippocampus, neocortex, and spinal cord from individuals affected with ALS and FTLDU.
Cleaved to generate C-terminal fragments in hippocampus, neocortex, and spinal cord from individuals affected with ALS and FTLDU.

Cellular localization

Nucleus. In patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis, it is absent from the nucleus of affected neurons but it is the primary component of cytoplasmic ubiquitin-positive inclusion bodies.

Target information above from: UniProt accessionQ13148 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • ALS10 antibody
  • OTTHUMP00000002171 antibody
  • OTTHUMP00000002172 antibody
  • OTTHUMP00000002173 antibody
  • TADBP_HUMAN antibody
  • TAR DNA binding protein 43 antibody
  • TAR DNA binding protein antibody
  • TAR DNA-binding protein 43 antibody
  • TARDBP antibody
  • TDP 43 antibody
  • TDP-43 antibody
  • TDP43 antibody
see all

Anti-TARDBP antibody images:

  Western blot - TARDBP antibody (ab50930)

Western blot - TARDBP antibody (ab50930)

Anti-TARDBP antibody (ab50930) at 1.25 µg/ml + HepG2 cell lysate at 10 µg

Secondary
HRP conjugated anti-Rabbit IgG at 1/50000 dilution

Predicted band size : 45 kDa
Observed band size : 45 kDa


Diluted in 5% skim milk / PBS buffer, gel concentration 12%

  Immunohistochemistry (Paraffin-embedded sections) - TARDBP antibody (ab50930)

Immunohistochemistry (Paraffin-embedded sections) - TARDBP antibody (ab50930)

Ab50930 at 4.0 µg/ml staining epithelial cells of renal tubule from Human kidney; paraffin embedded, magnification 400x.

  Immunohistochemistry (Paraffin-embedded sections) - TARDBP antibody (ab50930)

Immunohistochemistry (Paraffin-embedded sections) - TARDBP antibody (ab50930)

Ab50930 at 4.0 µg/ml staining Human liver hepatocytes; paraffin embedded, magnification 400x.

References for Anti-TARDBP antibody (ab50930)

This product has been referenced in:

  • Estes PSet al. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet 20:2308-21 (2011). WB.Read more (PubMed: 21441568) »

See 1 publication for this product

Publishing research using ab50930? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"